Aster Capital Management »

Miragen Therapeutics shares owned by Aster Capital Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Aster Capital Management from 13F filings

Historical chart of Aster Capital Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Aster Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Aster Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $35k 1.6k 21.58

More positions owned by Aster Capital Management

Johnson & Johnson (JNJ)
Capital One Financial (COF)
Wal-Mart Stores (WMT)
Abbott Laboratories (ABT)
Hca Holdings (HCA)
Wells Fargo & Company (WFC)
Home Depot (HD)
Bank of America Corporation (BAC)
Pulte (PHM)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Citigroup Com New (C)
Raymond James Financial (RJF)
Abbvie (ABBV)
Ishares Tr Ishares Biotech (IBB)
Carlisle Companies (CSL)

View all positions for Aster Capital Management

Top funds holding Miragen Therapeutics

FMR
BlackRock
Deep Track Capital
Kynam Capital Management
Vanguard Group
VR Adviser
Fairmount Funds Management
Commodore Capital
Tang Capital Management
Paradigm Biocapital Advisors
State Street Corporation
Novo A/S
Maverick Capital
Eversept Partners
Alliancebernstein

View all funds holding Miragen Therapeutics